Stock Analysis
Labcorp Holdings Inc. (LH) Stock Analysis
Labcorp Holdings Inc. (LH) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.
Labcorp Holdings Inc. (LH) currently has an AIQ Score of 48/100, indicating a neutral setup. Risk is the strongest factor at 64/100. Momentum is the weakest current factor at 31/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
LH at a Glance
Crawlable current metrics from the latest market-close stock snapshot.
| Metric | Current |
|---|---|
| Price | $311.54 |
| AIQ Score | 48/100 |
| Overall View | Neutral |
| Technical Analysis Consensus | Sell |
| Market Cap | $26.86B |
| P/E Ratio | 19.44 |
| Forward P/E | — |
| EPS | $3.66 |
| Revenue TTM | $3.73B |
| Dividend Yield | 0.00% |
| Beta | 0.84 |
| Volume | 809.93K |
| 52-week range | $244.52-$341.80 |
| RSI 14 | 25.05 |
| 50-Day SMA | $309.52 |
| 200-Day SMA | $276.66 |
| Analyst Price Target | $329.29 |
| Next Earnings | Oct 27, 2026 |
Create a free account to keep researching stocks
You have viewed 2 stock pages in the last 24 hours. Create a free account to keep researching current evidence.
LH
OverviewLH Stock Analysis Summary
Labcorp Holdings Inc. (LH) currently has an AIQ Score of 48/100, indicating a neutral setup. Risk resilience is the strongest factor at 64/100. Momentum is the weakest current factor at 31/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
In a neutral regime, LH has AIQ Score of 48/100 with Risk resilience base of 64/100 and fading Momentum at 31/100. Wait for component alignment before adding exposure.
Risk resilience (64/100) leads while Momentum (31/100) lags. This cross-factor spread creates entry timing uncertainty.
Healthcare · 1.49% stock move · LH classified in Medical - Diagnostics & Research.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is LH Bullish or Bearish Right Now?
LH currently has a neutral overall setup. Risk Resilience is the strongest factor at 64/100, while Momentum is weakest at 31/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.
- - Risk Resilience is supportive at 64/100.
- - Price is +0.65% above its 50-day SMA.
- - Analyst target implies +5.70% upside from the latest quote.
- - Momentum is weak at 31/100.
- - Technical consensus has more sell votes than buy votes (29 vs 15).
Current Consensus
LH's Technical Analysis Consensus is currently Sell, with 15 buy, 1 neutral, and 29 sell votes. LH's 14-day RSI is 25.05, which places the stock in an oversold momentum range. LH's beta is 0.84, indicating market sensitivity broadly in line with the market.
What Changed in LH?
Recent score-change history is not available in the current snapshot. These are the latest market-close scores instead.
What Would Change the LH Outlook?
The current neutral outlook could improve if AIQ moves above 70, momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 40, price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.
AIQ > 70, RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.
AIQ below 40, RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
LH Decision Framework
Public evidence layers, setup checks, and risk context for Labcorp Holdings Inc..
Labcorp Holdings Inc. (LH) Stock Analysis
Labcorp Holdings Inc. has an AIQ Score of 48/100 in a Neutral regime. Risk is strongest at 64/100. Beta is 0.84, below market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | LH is in a Neutral AIQ regime with score 48/100. |
| Signal Conflict | The primary conflict is that risk leads at 64/100 while momentum lags at 31/100. |
| Factor Evidence | Momentum 31/100 · Value 59/100 · Quality 42/100 · Risk 64/100 · Sentiment 64/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
Current Setup Checklist
Risk is the strongest factor at 64/100.
Momentum is 31/100 and RSI (14) is 25.1.
LH is in a Neutral regime at 48/100.
Risk factor is 64/100 with beta 0.84 and annual volatility 24.09%.
Current conflict: risk leads at 64/100 while momentum lags at 31/100.
LH Research Cluster
Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.
LH Fundamentals
LH valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.
LH Technical Analysis
LH technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
LH Stock Catalysts
Track LH earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.
LH Dividend Analysis
LH dividend yield, annual dividend, payout ratio, payment history, and income reliability context.
LH Financial Data
LH revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.
LH Risk Analysis
LH volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
LH Stock News
LH stock news, market tone, recent headlines, and catalyst context.
LH vs Healthcare Services / Managed Care Peers
Current peer cohort: LH · MCK · MOH · OSCR · PGNY. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.
| Peer | AIQ | Value | Momentum | Risk | Sharpe | 1Y Volatility | Compare |
|---|---|---|---|---|---|---|---|
| LH Current stock | 48/100 | 59/100 | 31/100 | 64/100 | 0.51 | 24.09% | Current |
| MCK McKesson | 48/100 | 58/100 | 56/100 | 50/100 | 0.74 | 31.32% | LH vs MCK |
| MOH Molina Healthcare | 46/100 | 50/100 | 54/100 | 57/100 | 0.45 | 53.18% | LH vs MOH |
| OSCR Oscar Health | 64/100 | 59/100 | 65/100 | 29/100 | 1.03 | 70.62% | LH vs OSCR |
| PGNY Progyny | 58/100 | 51/100 | 62/100 | 70/100 | 0.54 | 55.25% | LH vs PGNY |
Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Sep 11, 2026.
About the AIQ Score
Methodology for the current stock evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalysts7 recent quarterly periods are available for review.
Checked Sep 12, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
Fundamentals Verdict
Current snapshot fields are separate from reported-quarter statement tables.
Latest period Jun 30, 2026.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Continue Researching LH
Open the detailed evidence pages and workflows behind the stock overview read.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for LH
Scenario Analysis
AIQ Scenario Builder
Portfolio Implication
Related Links
LH Stock FAQ
What is LH stock price today?
Labcorp Holdings Inc.'s current stock price is $311.54. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.
Is LH bullish or bearish right now?
LH's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.
What is LH's market cap?
LH's market cap is $26.86B based on the latest completed market-close snapshot from Sep 11, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.
What is LH's current P/E ratio?
LH's current P/E ratio is 19.44 based on the latest completed market-close snapshot from Sep 11, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.
What is LH's RSI?
LH's 14-day RSI is 25.05 based on the latest completed market-close snapshot from Sep 11, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.
Is LH above its 50-day and 200-day moving averages?
LH is 0.65% from its 50-day SMA and 12.61% from its 200-day SMA based on the latest completed market-close snapshot from Sep 11, 2026. Moving-average position should be read with momentum and broader AIQ evidence.
When is LH's next earnings date?
LH's next earnings date is currently listed as Oct 27, 2026. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.
Does LH pay a dividend?
LH's dividend yield is 0.00% based on the latest completed market-close snapshot from Sep 11, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.